Anti-Rubella sp IgG Seroprevalence of and Associated Risk Factors in Pregnant Women at the Mother and Child Hospital and the Union Hospital, N'Djamena/Chad
Séroprévalence des IgG Anti-Rubella sp et Facteurs de Risque Associés Chez la Femme Enceinte à l’Hôpital Mère et Enfant, et l’Hôpital de l’Union, N’Djamena/Tchad
DOI:
https://doi.org/10.5281/hra.v2i6.5742Keywords:
seroprevalence, ELISA, Pregnant woman, Rubella sp, Risk factors, ChadAbstract
RÉSUMÉ
Contexte. Rubella sp est un agent pathogène tératogène, responsable de 2 à 3% des malformations congénitales chez les fœtus de mères infectées. Cette étude avait pour objectif de déterminer la séroprévalence de la rubéole, ainsi que les facteurs associés chez les femmes venues en consultation prénatale à l’Hôpital de l’Union et l’Hôpital Mère et Enfant de N’Djaména. Méthodes. C’était une étude transversale sur 3 mois. Après administration d’un questionnaire, un échantillon sanguin a été obtenu de chaque participante, puis analysé à l’aide du kit ELISA IgG RUB pour la recherche des anticorps IgG spécifiques. L’analyse statistique a été réalisée à l’aide du logiciel Microsoft Excel 2021, SPSS v25 et Past3. Les valeurs de p<0,05 et l’OR>1 étaient statistiquement significatifs à IC 95%. Résultats. La séroprévalence des IgG anti-Rubella obtenue était de 85,5%. Les facteurs de risques associés à la rubéole étaient : l’âge (p= 0,000068), le lieu de résidence (OR= 1,1574 ; IC : [0,3446 ; 3,887]), le niveau d’étude (p=0,0079), la profession (p=0,000086), l’âge gestationnel (p=0,00802), le statut matrimonial (OR= 3,125 ; IC : [0,2626 ; 37,19]) et la non-connaissance de la rubéole (OR=1,1613 ; IC : [0,1151 ; 11,72]). Conclusion. Il en ressort que le virus de la rubéole circule très activement au Tchad et sa transmission est associée à divers facteurs de risque.
ABSTRACT
Background. Rubella sp is a teratogenic pathogen, responsible of 2 to 3% of birth defects in infected mother’s fetuses. The study aim was to determine the seroprevalence of rubella, as well as the associated factors in women who came to prenatal consultation at the Union Hospital and at the Mother and Child Hospital of N'Djaména. Methods. It was a cross-sectional study over 3 months. After administering a questionnaire, a blood sample was obtained from each participant and analyzed using the IgG RUB ELISA kit for specific IgG antibodies. Statistical analysis was performed using Microsoft Excel 2021, SPSS v25 and Past3 software. The p<0.05 and OR>1 values were statistically significant at 95% CI. Results. Seroprevalence of anti-Rubella IgG was 85.5%. Risk factors associated with rubella were: age (p = 0.000068), place of residence (OR = 1.1574; CI: [0.3446; 3.887]), level of education (p = 0.0079), occupation (p = 0.000086), gestational age (p = 0.00802), marital status (OR = 3.125; CI: [0.2626; 37.19] and the lack of rubella (OR=1,1613; IC: [0,1151; 11,72]). Conclusion. It appears that the rubella virus circulates very actively in Chad and its transmission is associated with various risk factors.
References
Mengouo, M. N.; Ndze, V. N.; Baonga, F.; Kobela, M.; Wiysonge, C. S. Epidemiology of Rubella Infection in Cameroon: A 7-Year Experience of Measles and Rubella Case-Based Surveillance, 2008–2014. BMJ Open 2017, 7 (4), e012959. https://doi.org/10.1136/bmjopen-2016-012959.
Nabizadeh, E.; Ghotaslou, A.; Salahi, B.; Ghotaslou, R. The Screening of Rubella Virus, Cytomegalovirus, Hepatitis B Virus, and Toxoplasma Gondii Antibodies in Prepregnancy and Reproductive-Age Women in Tabriz, Iran. Infect. Dis. Obstet. Gynecol. 2022, 2022. https://doi.org/10.1155/2022/4490728.
OMS. Hépatite B. https://www.who.int/fr/news-room/fact-sheets/detail/hepatitis-b (accessed 2023-08-25).
Pejcic, I.; Rankovic Janevski, M.; Knezevic, A.; Jevtovic, D.; Stanojevic, M. Rubella Immune Status of Neonates – a Window towards Seroprevalence among Childbearing Women. BMC Public Health 2016, 16 (1), 838. https://doi.org/10.1186/s12889-016-3514-y.
Abdallah, S.; Massenet, D. Toxoplasmose et roubeole chez la femme enceinte au Tchad: enquete preliminaire. Bull Liaison Doc - OCEAC 1994, 43–44.
Oyinloye, S. O.; Amama, C. A.; Daniel, R.; Ajayi, B. B.; Lawan, M. A. Seroprevalence Survey of Rubella Antibodies among Pregnant Women in Maiduguri, Borno State, Nigeria. Afr. J. Clin. Exp. Microbiol. 2014, 15 (3). https://doi.org/10.4314/ajcem.v15i3.6.
Bola, O. O.; Korode, T. O.; Oguntunnbi, D. E.; Ajimojuowo, F. B.; Aladejare, A. A.; Jegede, O.; Adeniyi, O. S. Seroprevalence Of Rubella Virus Antibodies Among Pregnant Women Attending Antenatal Clinic in Ekiti State. Eur. J. Med. Health Sci. 2021, 3 (3). https://doi.org/10.24018/ejmed.2021.3.3.811.
Todjom, F. G.; Tsapi, E. M.; Gamago, G. A.; Vignoles, P.; Pone, J. W.; Teukeng, F. F. D. Seroprevalence of Toxoplasmosis and Associated Risk Factors in Pregnant Women at the Protestant Hospital, Mbouo-Bandjoun, Cameroon. Afr. J. Clin. Exp. Microbiol. 2019, 20 (3), 221–230. https://doi.org/10.4314/ajcem.v20i3.7.
Mabeku, L.; Tchakounté, C.; Salomon, T.; Etoa, F.-X. Prevalence of Toxoplasma Gondii and Associated Risk Factors among Pregnant Women Attending Hospital Centers in Penka-Michel, Cameroon. J. Sci. Res. Rep. 2018, 21. https://doi.org/10.9734/JSRR/2018/33061.
Makemgue, L. S.; Tonye; Boyé; Seck; Bercion; Vauloup-Fellous; T. Tchuente. Seroprevalence of rubella igg antibody in pregnant women in Yaounde, Cameroon. Semantic scholar. https://www.semanticscholar.org/paper/SEROPREVALENCE-OF-RUBELLA-IgG-ANTIBODY-IN-PREGNANT-Makemgue-Tonye/978f1ae1c0bd4d4c55a5eb8ef358f0dff572d4e8 (accessed 2023-08-06).
Nguemaïm, N. F.; Takang, W. A.; Dobgima, W. P.; Guebidiang, B. M.; Foumane, P.; Kamga, F. H. L. Seroprevalence of Toxoplasma Gondii Infection and Associated Risk Factors among Pregnant Women Attending Antenatal Clinic at the Bamenda Regional Hospital, Cameroon. Afr. J. Clin. Exp. Microbiol. 2020, 21 (2), 123–131. https://doi.org/10.4314/ajcem.v21i2.6.
Aminu, M.; Olajide, O.; Randawa, A., Jibril; Adejo, D., Stephen. Seroprevalence of Rubella-Specific IgM and IgG Antibodies among Pregnant Women Seen in a Tertiary Hospital in Nigeria. Int. J. Womens Health 2015, 75. https://doi.org/10.2147/IJWH.S68667.
Taku, N. A.; Ndze, V. N.; Abernathy, E.; Hao, L. J.; Waku-Kouomou, D.; Icenogle, J. P.; Wanji, S.; Akoachere, J. F. K. T. Seroprevalence of Rubella Virus Antibodies among Pregnant Women in the Center and South-West Regions of Cameroon. PLoS ONE 2019, 14 (11). https://doi.org/10.1371/journal.pone.0225594.
Eno, A. A.; Makemgue, L. S.; Tonye Iii, D. S.; Boye, C. S. B.; Seck, A.; Bercion, R.; Vauloup Fellous, C.; Tchuem Tchuente, L. A. Seroprevalence of Rubella-Specific IgM and IgG Antibodies among Pregnant Women in a Catholic Hospital in Yaoundé, Cameroon. Int. J. Biol. Chem. Sci. 2018, 12 (3), 1123. https://doi.org/10.4314/ijbcs.v12i3.4.
Adam, O.; Makkawi, T.; Kannan, A.; Osman, M. E. Seroprevalence of Rubella among Pregnant Women in Khartoum State, Sudan. East. Mediterr. Health J. 2013, 19 (9). https://doi.org/10.26719/2013.19.9.812.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Njiki Bikoï Jacky, Makemgue Louise Stéphanie, Touangnou Chamda Sabine Aimée, Limane Adjobma Basile, Togyedji Djoyalbaye, Alladoum Kadounia Jean-Jacques, Djangbeye Loumadou, Bakna Michael, Ngo Um Meka Esther
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC BY-NC-ND 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
